The market is mainly driven by the significant applications of Gout Drugs in various end use industries. The expanding demands from the Acute gout and Chronic gout, are propelling Gout Drugs market. Febuxostat, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Benzbromo Malone segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gout Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Gout Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Gout Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gout Drugs sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Gout Drugs covered in this report include Sun Pharma, Mylan, Apotex, Northstar, Ipca, Accord, Synpac-Kingdom, PIDI and KPC, etc.

The global Gout Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Sun Pharma

Mylan

Apotex

Northstar

Ipca

Accord

Synpac-Kingdom

PIDI

KPC

Yunnan Phytopharmaceutical

Scope of Gout Drugs - Market Report

Report Metric	Details
Report Name	Gout Drugs - Market
Forecasted market size in 2029	US$ 6228.7 million
CAGR	12.0%
Forecasted years	2023 - 2029
Global Gout Drugs market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gout Drugs market, Segment by Type:	Febuxostat Benzbromo Malone Allopurinol Colchicine Other
Global Gout Drugs market, by Application	Acute gout Chronic gout
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Gout Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Gout Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Gout Drugs - Market size in 2029?

Ans: The Gout Drugs - Market size in 2029 will be US$ 6228.7 million.

What are the Application segmentation covered in the Gout Drugs - Market report?

Ans: The Applications covered in the Gout Drugs - Market report are Acute gout, Chronic gout

What are the Type segmentation covered in the Gout Drugs - Market report?

Ans: The Types covered in the Gout Drugs - Market report are Febuxostat, Benzbromo Malone, Allopurinol, Colchicine, Other

1 Gout Drugs Market Overview

1.1 Gout Drugs Product Overview

1.2 Gout Drugs Market Segment by Type

1.2.1 Febuxostat

1.2.2 Benzbromo Malone

1.2.3 Allopurinol

1.2.4 Colchicine

1.2.5 Other

1.3 Global Gout Drugs Market Size by Type

1.3.1 Global Gout Drugs Market Size Overview by Type (2018-2029)

1.3.2 Global Gout Drugs Historic Market Size Review by Type (2018-2023)

1.3.3 Global Gout Drugs Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Gout Drugs Sales Breakdown by Type (2018-2023)

1.4.2 Europe Gout Drugs Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Gout Drugs Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Gout Drugs Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Gout Drugs Sales Breakdown by Type (2018-2023)

2 Global Gout Drugs Market Competition by Company

2.1 Global Top Players by Gout Drugs Sales (2018-2023)

2.2 Global Top Players by Gout Drugs Revenue (2018-2023)

2.3 Global Top Players by Gout Drugs Price (2018-2023)

2.4 Global Top Manufacturers Gout Drugs Manufacturing Base Distribution, Sales Area, Product Type

2.5 Gout Drugs Market Competitive Situation and Trends

2.5.1 Gout Drugs Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Gout Drugs Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gout Drugs as of 2022)

2.7 Date of Key Manufacturers Enter into Gout Drugs Market

2.8 Key Manufacturers Gout Drugs Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Gout Drugs Status and Outlook by Region

3.1 Global Gout Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Gout Drugs Historic Market Size by Region

3.2.1 Global Gout Drugs Sales in Volume by Region (2018-2023)

3.2.2 Global Gout Drugs Sales in Value by Region (2018-2023)

3.2.3 Global Gout Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Gout Drugs Forecasted Market Size by Region

3.3.1 Global Gout Drugs Sales in Volume by Region (2024-2029)

3.3.2 Global Gout Drugs Sales in Value by Region (2024-2029)

3.3.3 Global Gout Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Gout Drugs by Application

4.1 Gout Drugs Market Segment by Application

4.1.1 Acute gout

4.1.2 Chronic gout

4.2 Global Gout Drugs Market Size by Application

4.2.1 Global Gout Drugs Market Size Overview by Application (2018-2029)

4.2.2 Global Gout Drugs Historic Market Size Review by Application (2018-2023)

4.2.3 Global Gout Drugs Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Gout Drugs Sales Breakdown by Application (2018-2023)

4.3.2 Europe Gout Drugs Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Gout Drugs Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Gout Drugs Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Gout Drugs Sales Breakdown by Application (2018-2023)

5 North America Gout Drugs by Country

5.1 North America Gout Drugs Historic Market Size by Country

5.1.1 North America Gout Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Gout Drugs Sales in Volume by Country (2018-2023)

5.1.3 North America Gout Drugs Sales in Value by Country (2018-2023)

5.2 North America Gout Drugs Forecasted Market Size by Country

5.2.1 North America Gout Drugs Sales in Volume by Country (2024-2029)

5.2.2 North America Gout Drugs Sales in Value by Country (2024-2029)

6 Europe Gout Drugs by Country

6.1 Europe Gout Drugs Historic Market Size by Country

6.1.1 Europe Gout Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Gout Drugs Sales in Volume by Country (2018-2023)

6.1.3 Europe Gout Drugs Sales in Value by Country (2018-2023)

6.2 Europe Gout Drugs Forecasted Market Size by Country

6.2.1 Europe Gout Drugs Sales in Volume by Country (2024-2029)

6.2.2 Europe Gout Drugs Sales in Value by Country (2024-2029)

7 Asia-Pacific Gout Drugs by Region

7.1 Asia-Pacific Gout Drugs Historic Market Size by Region

7.1.1 Asia-Pacific Gout Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Gout Drugs Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Gout Drugs Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Gout Drugs Forecasted Market Size by Region

7.2.1 Asia-Pacific Gout Drugs Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Gout Drugs Sales in Value by Region (2024-2029)

8 Latin America Gout Drugs by Country

8.1 Latin America Gout Drugs Historic Market Size by Country

8.1.1 Latin America Gout Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Gout Drugs Sales in Volume by Country (2018-2023)

8.1.3 Latin America Gout Drugs Sales in Value by Country (2018-2023)

8.2 Latin America Gout Drugs Forecasted Market Size by Country

8.2.1 Latin America Gout Drugs Sales in Volume by Country (2024-2029)

8.2.2 Latin America Gout Drugs Sales in Value by Country (2024-2029)

9 Middle East and Africa Gout Drugs by Country

9.1 Middle East and Africa Gout Drugs Historic Market Size by Country

9.1.1 Middle East and Africa Gout Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Gout Drugs Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Gout Drugs Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Gout Drugs Forecasted Market Size by Country

9.2.1 Middle East and Africa Gout Drugs Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Gout Drugs Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Sun Pharma

10.1.1 Sun Pharma Company Information

10.1.2 Sun Pharma Introduction and Business Overview

10.1.3 Sun Pharma Gout Drugs Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Sun Pharma Gout Drugs Products Offered

10.1.5 Sun Pharma Recent Development

10.2 Mylan

10.2.1 Mylan Company Information

10.2.2 Mylan Introduction and Business Overview

10.2.3 Mylan Gout Drugs Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Mylan Gout Drugs Products Offered

10.2.5 Mylan Recent Development

10.3 Apotex

10.3.1 Apotex Company Information

10.3.2 Apotex Introduction and Business Overview

10.3.3 Apotex Gout Drugs Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Apotex Gout Drugs Products Offered

10.3.5 Apotex Recent Development

10.4 Northstar

10.4.1 Northstar Company Information

10.4.2 Northstar Introduction and Business Overview

10.4.3 Northstar Gout Drugs Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Northstar Gout Drugs Products Offered

10.4.5 Northstar Recent Development

10.5 Ipca

10.5.1 Ipca Company Information

10.5.2 Ipca Introduction and Business Overview

10.5.3 Ipca Gout Drugs Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Ipca Gout Drugs Products Offered

10.5.5 Ipca Recent Development

10.6 Accord

10.6.1 Accord Company Information

10.6.2 Accord Introduction and Business Overview

10.6.3 Accord Gout Drugs Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Accord Gout Drugs Products Offered

10.6.5 Accord Recent Development

10.7 Synpac-Kingdom

10.7.1 Synpac-Kingdom Company Information

10.7.2 Synpac-Kingdom Introduction and Business Overview

10.7.3 Synpac-Kingdom Gout Drugs Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Synpac-Kingdom Gout Drugs Products Offered

10.7.5 Synpac-Kingdom Recent Development

10.8 PIDI

10.8.1 PIDI Company Information

10.8.2 PIDI Introduction and Business Overview

10.8.3 PIDI Gout Drugs Sales, Revenue and Gross Margin (2018-2023)

10.8.4 PIDI Gout Drugs Products Offered

10.8.5 PIDI Recent Development

10.9 KPC

10.9.1 KPC Company Information

10.9.2 KPC Introduction and Business Overview

10.9.3 KPC Gout Drugs Sales, Revenue and Gross Margin (2018-2023)

10.9.4 KPC Gout Drugs Products Offered

10.9.5 KPC Recent Development

10.10 Yunnan Phytopharmaceutical

10.10.1 Yunnan Phytopharmaceutical Company Information

10.10.2 Yunnan Phytopharmaceutical Introduction and Business Overview

10.10.3 Yunnan Phytopharmaceutical Gout Drugs Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Yunnan Phytopharmaceutical Gout Drugs Products Offered

10.10.5 Yunnan Phytopharmaceutical Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Gout Drugs Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Gout Drugs Industrial Chain Analysis

11.4 Gout Drugs Market Dynamics

11.4.1 Gout Drugs Industry Trends

11.4.2 Gout Drugs Market Drivers

11.4.3 Gout Drugs Market Challenges

11.4.4 Gout Drugs Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Gout Drugs Distributors

12.3 Gout Drugs Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Yunnan Phytopharmaceutical

List of Tables

Table 1. Major Company of Febuxostat

Table 2. Major Company of Benzbromo Malone

Table 3. Major Company of Allopurinol

Table 4. Major Company of Colchicine

Table 5. Major Company of Other

Table 6. Global Gout Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 7. Global Gout Drugs Sales by Type (2018-2023) & (K Units)

Table 8. Global Gout Drugs Sales Market Share in Volume by Type (2018-2023)

Table 9. Global Gout Drugs Sales by Type (2018-2023) & (US& Million)

Table 10. Global Gout Drugs Market Share in Value by Type (2018-2023)

Table 11. Global Gout Drugs Price by Type (2018-2023) & (USD/Unit)

Table 12. Global Gout Drugs Sales by Type (2024-2029) & (K Units)

Table 13. Global Gout Drugs Sales Market Share in Volume by Type (2024-2029)

Table 14. Global Gout Drugs Sales by Type (2024-2029) & (US$ Million)

Table 15. Global Gout Drugs Sales Market Share in Value by Type (2024-2029)

Table 16. Global Gout Drugs Price by Type (2024-2029) & (USD/Unit)

Table 17. North America Gout Drugs Sales by Type (2018-2023) & (K Units)

Table 18. North America Gout Drugs Sales by Type (2018-2023) & (US$ Million)

Table 19. Europe Gout Drugs Sales (K Units) by Type (2018-2023)

Table 20. Europe Gout Drugs Sales by Type (2018-2023) & (US$ Million)

Table 21. Asia-Pacific Gout Drugs Sales (K Units) by Type (2018-2023)

Table 22. Asia-Pacific Gout Drugs Sales by Type (2018-2023) & (US$ Million)

Table 23. Latin America Gout Drugs Sales (K Units) by Type (2018-2023)

Table 24. Latin America Gout Drugs Sales by Type (2018-2023) & (US$ Million)

Table 25. Middle East and Africa Gout Drugs Sales (K Units) by Type (2018-2023)

Table 26. Middle East and Africa Gout Drugs Sales by Type (2018-2023) & (US$ Million)

Table 27. Global Gout Drugs Sales by Company (2018-2023) & (K Units)

Table 28. Global Gout Drugs Sales Share by Company (2018-2023)

Table 29. Global Gout Drugs Revenue by Company (2018-2023) & (US$ Million)

Table 30. Global Gout Drugs Revenue Share by Company (2018-2023)

Table 31. Global Market Gout Drugs Price by Company (2018-2023) & (USD/Unit)

Table 32. Global Gout Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 33. Global Gout Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gout Drugs as of 2022)

Table 35. Date of Key Manufacturers Enter into Gout Drugs Market

Table 36. Key Manufacturers Gout Drugs Product Type

Table 37. Mergers & Acquisitions, Expansion Plans

Table 38. Global Gout Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 39. Global Gout Drugs Sales by Region (2018-2023) & (K Units)

Table 40. Global Gout Drugs Sales Market Share in Volume by Region (2018-2023)

Table 41. Global Gout Drugs Sales by Region (2018-2023) & (US$ Million)

Table 42. Global Gout Drugs Sales Market Share in Value by Region (2018-2023)

Table 43. Global Gout Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 44. Global Gout Drugs Sales by Region (2024-2029) & (K Units)

Table 45. Global Gout Drugs Sales Market Share in Volume by Region (2024-2029)

Table 46. Global Gout Drugs Sales by Region (2024-2029) & (US$ Million)

Table 47. Global Gout Drugs Sales Market Share in Value by Region (2024-2029)

Table 48. Global Gout Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)

Table 49. Global Gout Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 50. Global Gout Drugs Sales by Application (2018-2023) & (K Units)

Table 51. Global Gout Drugs Sales Market Share in Volume by Application (2018-2023)

Table 52. Global Gout Drugs Sales by Application (2018-2023) & (US$ Million)

Table 53. Global Gout Drugs Sales Market Share in Value by Application (2018-2023)

Table 54. Global Gout Drugs Price by Application (2018-2023) & (USD/Unit)

Table 55. Global Gout Drugs Sales by Application (2024-2029) & (K Units)

Table 56. Global Gout Drugs Sales Market Share in Volume by Application (2024-2029)

Table 57. Global Gout Drugs Sales by Application (2024-2029) & (US$ Million)

Table 58. Global Gout Drugs Sales Market Share in Value by Application (2024-2029)

Table 59. Global Gout Drugs Price by Application (2024-2029) & (USD/Unit)

Table 60. North America Gout Drugs Sales by Application (2018-2023) (K Units)

Table 61. North America Gout Drugs Sales by Application (2018-2023) & (US$ Million)

Table 62. Europe Gout Drugs Sales by Application (2018-2023) (K Units)

Table 63. Europe Gout Drugs Sales by Application (2018-2023) & (US$ Million)

Table 64. Asia-Pacific Gout Drugs Sales by Application (2018-2023) (K Units)

Table 65. Asia-Pacific Gout Drugs Sales by Application (2018-2023) & (US$ Million)

Table 66. Latin America Gout Drugs Sales by Application (2018-2023) (K Units)

Table 67. Latin America Gout Drugs Sales by Application (2018-2023) & (US$ Million)

Table 68. Middle East and Africa Gout Drugs Sales by Application (2018-2023) (K Units)

Table 69. Middle East and Africa Gout Drugs Sales by Application (2018-2023) & (US$ Million)

Table 70. North America Gout Drugs Sales by Country (2018-2023) & (K Units)

Table 71. North America Gout Drugs Sales Market Share in Volume by Country (2018-2023)

Table 72. North America Gout Drugs Sales by Country (2018-2023) & (US$ Million)

Table 73. North America Gout Drugs Sales Market Share in Value by Country (2018-2023)

Table 74. North America Gout Drugs Sales by Country (2024-2029) & (K Units)

Table 75. North America Gout Drugs Sales Market Share in Volume by Country (2024-2029)

Table 76. North America Gout Drugs Sales by Country (2024-2029) & (US$ Million)

Table 77. North America Gout Drugs Sales Market Share in Value by Country (2024-2029)

Table 78. Europe Gout Drugs Sales by Country (2018-2023) & (K Units)

Table 79. Europe Gout Drugs Sales Market Share in Volume by Country (2018-2023)

Table 80. Europe Gout Drugs Sales by Country (2018-2023) & (US$ Million)

Table 81. Europe Gout Drugs Sales Market Share in Value by Country (2018-2023)

Table 82. Europe Gout Drugs Sales by Country (2024-2029) & (K Units)

Table 83. Europe Gout Drugs Sales Market Share in Volume by Country (2024-2029)

Table 84. Europe Gout Drugs Sales by Country (2024-2029) & (US$ Million)

Table 85. Europe Gout Drugs Sales Market Share in Value by Country (2024-2029)

Table 86. Asia-Pacific Gout Drugs Sales by Region (2018-2023) & (K Units)

Table 87. Asia-Pacific Gout Drugs Sales Market Share in Volume by Region (2018-2023)

Table 88. Asia-Pacific Gout Drugs Sales by Region (2018-2023) & (US$ Million)

Table 89. Asia-Pacific Gout Drugs Sales Market Share in Value by Region (2018-2023)

Table 90. Asia-Pacific Gout Drugs Sales by Region (2024-2029) & (K Units)

Table 91. Asia-Pacific Gout Drugs Sales Market Share in Volume by Region (2024-2029)

Table 92. Asia-Pacific Gout Drugs Sales by Region (2024-2029) & (US$ Million)

Table 93. Asia-Pacific Gout Drugs Sales Market Share in Value by Region (2024-2029)

Table 94. Latin America Gout Drugs Sales by Country (2018-2023) & (K Units)

Table 95. Latin America Gout Drugs Sales Market Share in Volume by Country (2018-2023)

Table 96. Latin America Gout Drugs Sales by Country (2018-2023) & (US$ Million)

Table 97. Latin America Gout Drugs Sales Market Share in Value by Country (2018-2023)

Table 98. Latin America Gout Drugs Sales by Country (2024-2029) & (K Units)

Table 99. Latin America Gout Drugs Sales Market Share in Volume by Country (2024-2029)

Table 100. Latin America Gout Drugs Sales by Country (2024-2029) & (US$ Million)

Table 101. Latin America Gout Drugs Sales Market Share in Value by Country (2024-2029)

Table 102. Middle East and Africa Gout Drugs Sales by Country (2018-2023) & (K Units)

Table 103. Middle East and Africa Gout Drugs Sales Market Share in Volume by Country (2018-2023)

Table 104. Middle East and Africa Gout Drugs Sales by Country (2018-2023) & (US$ Million)

Table 105. Middle East and Africa Gout Drugs Sales Market Share in Value by Country (2018-2023)

Table 106. Middle East and Africa Gout Drugs Sales by Country (2024-2029) & (K Units)

Table 107. Middle East and Africa Gout Drugs Sales Market Share in Volume by Country (2024-2029)

Table 108. Middle East and Africa Gout Drugs Sales by Country (2024-2029) & (US$ Million)

Table 109. Middle East and Africa Gout Drugs Sales Market Share in Value by Country (2024-2029)

Table 110. Sun Pharma Company Information

Table 111. Sun Pharma Introduction and Business Overview

Table 112. Sun Pharma Gout Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 113. Sun Pharma Gout Drugs Product

Table 114. Sun Pharma Recent Development

Table 115. Mylan Company Information

Table 116. Mylan Introduction and Business Overview

Table 117. Mylan Gout Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 118. Mylan Gout Drugs Product

Table 119. Mylan Recent Development

Table 120. Apotex Company Information

Table 121. Apotex Introduction and Business Overview

Table 122. Apotex Gout Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 123. Apotex Gout Drugs Product

Table 124. Apotex Recent Development

Table 125. Northstar Company Information

Table 126. Northstar Introduction and Business Overview

Table 127. Northstar Gout Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 128. Northstar Gout Drugs Product

Table 129. Northstar Recent Development

Table 130. Ipca Company Information

Table 131. Ipca Introduction and Business Overview

Table 132. Ipca Gout Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 133. Ipca Gout Drugs Product

Table 134. Ipca Recent Development

Table 135. Accord Company Information

Table 136. Accord Introduction and Business Overview

Table 137. Accord Gout Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 138. Accord Gout Drugs Product

Table 139. Accord Recent Development

Table 140. Synpac-Kingdom Company Information

Table 141. Synpac-Kingdom Introduction and Business Overview

Table 142. Synpac-Kingdom Gout Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 143. Synpac-Kingdom Gout Drugs Product

Table 144. Synpac-Kingdom Recent Development

Table 145. PIDI Company Information

Table 146. PIDI Introduction and Business Overview

Table 147. PIDI Gout Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 148. PIDI Gout Drugs Product

Table 149. PIDI Recent Development

Table 150. KPC Company Information

Table 151. KPC Introduction and Business Overview

Table 152. KPC Gout Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 153. KPC Gout Drugs Product

Table 154. KPC Recent Development

Table 155. Yunnan Phytopharmaceutical Company Information

Table 156. Yunnan Phytopharmaceutical Introduction and Business Overview

Table 157. Yunnan Phytopharmaceutical Gout Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 158. Yunnan Phytopharmaceutical Gout Drugs Product

Table 159. Yunnan Phytopharmaceutical Recent Development

Table 160. Key Raw Materials Lists

Table 161. Raw Materials Key Suppliers Lists

Table 162. Gout Drugs Market Trends

Table 163. Gout Drugs Market Drivers

Table 164. Gout Drugs Market Challenges

Table 165. Gout Drugs Market Restraints

Table 166. Gout Drugs Distributors List

Table 167. Gout Drugs Downstream Customers

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

List of Figures

Figure 1. Gout Drugs Product Picture

Figure 2. Global Gout Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Gout Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Gout Drugs Sales Status and Outlook (2018-2029) & (K Units)

Figure 5. Product Picture of Febuxostat

Figure 6. Global Febuxostat Sales YoY Growth (2018-2029) & (K Units)

Figure 7. Product Picture of Benzbromo Malone

Figure 8. Global Benzbromo Malone Sales YoY Growth (2018-2029) & (K Units)

Figure 9. Product Picture of Allopurinol

Figure 10. Global Allopurinol Sales YoY Growth (2018-2029) & (K Units)

Figure 11. Product Picture of Colchicine

Figure 12. Global Colchicine Sales YoY Growth (2018-2029) & (K Units)

Figure 13. Product Picture of Other

Figure 14. Global Other Sales YoY Growth (2018-2029) & (K Units)

Figure 15. Global Gout Drugs Sales by Type (2018-2029) & (US$ Million)

Figure 16. Global Gout Drugs Sales Market Share by Type in 2022 & 2029

Figure 17. North America Gout Drugs Sales Market Share in Volume by Type in 2022

Figure 18. North America Gout Drugs Sales Market Share in Value by Type in 2022

Figure 19. Europe Gout Drugs Sales Market Share in Volume by Type in 2022

Figure 20. Europe Gout Drugs Sales Market Share in Value by Type in 2022

Figure 21. Asia-Pacific Gout Drugs Sales Market Share in Volume by Type in 2022

Figure 22. Asia-Pacific Gout Drugs Sales Market Share in Value by Type in 2022

Figure 23. Latin America Gout Drugs Sales Market Share in Volume by Type in 2022

Figure 24. Latin America Gout Drugs Sales Market Share in Value by Type in 2022

Figure 25. Middle East and Africa Gout Drugs Sales Market Share in Volume by Type in 2022

Figure 26. Middle East and Africa Gout Drugs Sales Market Share in Value by Type in 2022

Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Gout Drugs Sales in 2022

Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Gout Drugs Revenue in 2022

Figure 29. Gout Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 30. Product Picture of Acute gout

Figure 31. Global Acute gout Sales YoY Growth (2018-2029) & (K Units)

Figure 32. Product Picture of Chronic gout

Figure 33. Global Chronic gout Sales YoY Growth (2018-2029) & (K Units)

Figure 34. Global Gout Drugs Sales by Application (2018-2029) & (US$ Million)

Figure 35. Global Gout Drugs Sales Market Share by Application in 2022 & 2029

Figure 36. North America Gout Drugs Sales Market Share in Volume by Application in 2022

Figure 37. North America Gout Drugs Sales Market Share in Value by Application in 2022

Figure 38. Europe Gout Drugs Sales Market Share in Volume by Application in 2022

Figure 39. Europe Gout Drugs Sales Market Share in Value by Application in 2022

Figure 40. Asia-Pacific Gout Drugs Sales Market Share in Volume by Application in 2022

Figure 41. Asia-Pacific Gout Drugs Sales Market Share in Value by Application in 2022

Figure 42. Latin America Gout Drugs Sales Market Share in Volume by Application in 2022

Figure 43. Latin America Gout Drugs Sales Market Share in Value by Application in 2022

Figure 44. Middle East and Africa Gout Drugs Sales Market Share in Value by Application in 2022

Figure 45. Key Raw Materials Price

Figure 46. Gout Drugs Manufacturing Cost Structure

Figure 47. Gout Drugs Industrial Chain Analysis

Figure 48. Channels of Distribution

Figure 49. Distributors Profiles

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions